61 related articles for article (PubMed ID: 24303881)
1. Association of quantitative assessment of the intrafollicular proliferation index with outcome in follicular lymphoma.
Kedmi M; Hedvat CV; Maragulia J; Zhang Z; Zelenetz AD
Br J Haematol; 2014 Mar; 164(5):646-52. PubMed ID: 24303881
[TBL] [Abstract][Full Text] [Related]
2. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
3. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
4. Utility of SKP2 and MIB-1 in grading follicular lymphoma using quantitative imaging analysis.
Zhang K; Prichard JW; Yoder S; De J; Lin F
Hum Pathol; 2007 Jun; 38(6):878-82. PubMed ID: 17350668
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.
Martin AR; Weisenburger DD; Chan WC; Ruby EI; Anderson JR; Vose JM; Bierman PJ; Bast MA; Daley DT; Armitage JO
Blood; 1995 Jun; 85(12):3671-8. PubMed ID: 7780151
[TBL] [Abstract][Full Text] [Related]
7. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.
Wahlin BE; Yri OE; Kimby E; Holte H; Delabie J; Smeland EB; Sundström C; Christensson B; Sander B
Br J Haematol; 2012 Jan; 156(2):225-33. PubMed ID: 22126847
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
11. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes.
O'Connor OA; Portlock C; Moskowitz C; Hamlin P; Straus D; Gerecitano J; Gonen M; Dumitrescu O; Sarasohn D; Butos J; Neylon E; Mac-Gregor Cortelli B; Blumel S; Evens AM; Zelenetz AD; Wright J; Cooper B; Winter J; Vose J
Clin Cancer Res; 2010 Jan; 16(2):719-26. PubMed ID: 20068103
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
[TBL] [Abstract][Full Text] [Related]
13. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Canioni D; Salles G; Mounier N; Brousse N; Keuppens M; Morchhauser F; Lamy T; Sonet A; Rousselet MC; Foussard C; Xerri L
J Clin Oncol; 2008 Jan; 26(3):440-6. PubMed ID: 18086798
[TBL] [Abstract][Full Text] [Related]
14. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features.
Wang SA; Wang L; Hochberg EP; Muzikansky A; Harris NL; Hasserjian RP
Am J Surg Pathol; 2005 Nov; 29(11):1490-6. PubMed ID: 16224216
[TBL] [Abstract][Full Text] [Related]
15. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
Sun W; Caraway NP; Zhang HZ; Khanna A; Payne LG; Katz RL
Acta Cytol; 2004; 48(2):119-26. PubMed ID: 15085740
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma.
Tari A; Asaoku H; Kunihiro M; Tanaka S; Fujihara M; Yoshino T
Digestion; 2011; 83(3):191-7. PubMed ID: 21266815
[TBL] [Abstract][Full Text] [Related]
17. [Cut-off value of Ki-67 labeling index in the pathologic grading of follicular lymphoma].
Hou WH; Duan XK; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):696-699. PubMed ID: 30220124
[No Abstract] [Full Text] [Related]
18. The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Pham RN; Gooley TA; Keeney GE; Press OW; Pagel JM; Greisman HA; Bensinger WI; Holmberg LA; Petersdorf SH; Maloney DG; Gopal AK
Bone Marrow Transplant; 2007 Dec; 40(11):1039-44. PubMed ID: 17922043
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of PU.1 in follicular lymphoma.
Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
Hum Pathol; 1999 Mar; 30(3):263-8. PubMed ID: 10088543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
